MX371393B - Parche para tratamiento de enfermades del parpado que contiene clobetasol. - Google Patents

Parche para tratamiento de enfermades del parpado que contiene clobetasol.

Info

Publication number
MX371393B
MX371393B MX2015007611A MX2015007611A MX371393B MX 371393 B MX371393 B MX 371393B MX 2015007611 A MX2015007611 A MX 2015007611A MX 2015007611 A MX2015007611 A MX 2015007611A MX 371393 B MX371393 B MX 371393B
Authority
MX
Mexico
Prior art keywords
patch
treatment
sensitive adhesive
pressure
adhesive layer
Prior art date
Application number
MX2015007611A
Other languages
English (en)
Other versions
MX2015007611A (es
Inventor
Ogawa Takahiro
Isowaki Akiharu
Kawahara Koji
Hiraoka Takao
Tanaka Mariko
Kenmochi Chihiro
Original Assignee
Senju Usa Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Senju Usa Inc filed Critical Senju Usa Inc
Publication of MX2015007611A publication Critical patent/MX2015007611A/es
Publication of MX371393B publication Critical patent/MX371393B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M35/00—Devices for applying media, e.g. remedies, on the human body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/24—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7076—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising ingredients of undetermined constitution or reaction products thereof, e.g. rosin or other plant resins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/26—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/44—Medicaments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/58—Adhesives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L23/00—Compositions of homopolymers or copolymers of unsaturated aliphatic hydrocarbons having only one carbon-to-carbon double bond; Compositions of derivatives of such polymers
    • C08L23/02—Compositions of homopolymers or copolymers of unsaturated aliphatic hydrocarbons having only one carbon-to-carbon double bond; Compositions of derivatives of such polymers not modified by chemical after-treatment
    • C08L23/04—Homopolymers or copolymers of ethene
    • C08L23/06—Polyethene
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L67/00—Compositions of polyesters obtained by reactions forming a carboxylic ester link in the main chain; Compositions of derivatives of such polymers
    • C08L67/04—Polyesters derived from hydroxycarboxylic acids, e.g. lactones

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Materials Engineering (AREA)
  • Dermatology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Botany (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Anesthesiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Polymers & Plastics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Ophthalmology & Optometry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Un parche para tratamiento de enfermedades oftálmicas tales como enfermedades del párpado que se proporciona con un soporte, una capa adhesiva sensible a la presión, y una capa de liberación en este orden, en donde (a) la capa adhesiva sensible a la presión incluye los siguientes (a-1) hasta (a-4): (a-1) un copolímero de bloque de estireno-isopreno-estireno, una resina fijadora, y un agente suavizante están contenidos; (a-2) una relación (relación en masa) del copolímero de bloque de estireno-isopreno-estireno y la resina fijadora es 1:2 hasta 1:4; (a-3) un contenido del agente suavizante es 40% hasta 60% en masa; y (a-4) además 0.005% hasta 5% en masa de clobetasol o éster del mismo está contenido; y (b) el soporte tiene módulo elástico con un módulo de Young de 0.01 hasta 0.5 GPa: y un método para producir el parche para tratamiento de enfermedades oftálmicas tales como enfermedades del párpado incluyendo: formar la capa adhesiva sensible a la presión sobre una superficie superior de la capa de liberación.
MX2015007611A 2012-12-19 2013-12-17 Parche para tratamiento de enfermades del parpado que contiene clobetasol. MX371393B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13/719,406 US9211397B2 (en) 2012-12-19 2012-12-19 Patch for treatment of eyelid disease containing clobetasol
PCT/US2013/075631 WO2014099894A2 (en) 2012-12-19 2013-12-17 Patch for treatment of eyelid diseases containing clobetasol

Publications (2)

Publication Number Publication Date
MX2015007611A MX2015007611A (es) 2015-12-15
MX371393B true MX371393B (es) 2020-01-28

Family

ID=50931741

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2015007611A MX371393B (es) 2012-12-19 2013-12-17 Parche para tratamiento de enfermades del parpado que contiene clobetasol.

Country Status (10)

Country Link
US (1) US9211397B2 (es)
EP (1) EP2934403B1 (es)
JP (1) JP6288863B2 (es)
KR (1) KR102182433B1 (es)
CN (1) CN104955426B (es)
CA (1) CA2887589C (es)
ES (1) ES2666143T3 (es)
MX (1) MX371393B (es)
RU (1) RU2015129097A (es)
WO (1) WO2014099894A2 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11311423B2 (en) * 2012-12-19 2022-04-26 Nichiban Co., Ltd. Facial patch
US9463201B2 (en) 2014-10-19 2016-10-11 M.G. Therapeutics Ltd Compositions and methods for the treatment of meibomian gland dysfunction
CN113144203A (zh) * 2015-09-28 2021-07-23 阿祖拉眼科有限公司 用于增加睑板腺脂质分泌物的含硫醇及二硫化物的药剂
CN109946257A (zh) * 2019-02-26 2019-06-28 广东轻工职业技术学院 一种测定无纺布对苄索氯铵吸附速率的方法
CN114956378B (zh) * 2022-05-23 2023-04-14 江苏大学 吸附水中油滴的锥形阵列表面、油水分离网及其制备方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2036670T3 (es) 1987-03-09 1993-06-01 Alza Corporation Composicion para prevenir una alergia de contacto por administracion simultanea de un corticoesteroide con un farmaco sensibilizante.
US5000956A (en) 1987-03-09 1991-03-19 Alza Corporation Prevention of contact allergy by coadministration of a corticosteroid with a sensitizing drug
JPH0517346A (ja) 1991-07-04 1993-01-26 Sekisui Chem Co Ltd 医療用貼付剤
KR100209469B1 (ko) * 1994-10-05 1999-07-15 나까도미 히로다카 N-치환-o-톨루이딘유도체로 이루어진 약용배합제 및 경피흡수형 제제
US20020110585A1 (en) * 1999-11-30 2002-08-15 Godbey Kristin J. Patch therapeutic agent delivery device having texturized backing
KR20120035220A (ko) * 2003-01-22 2012-04-13 센주 세이야꾸 가부시키가이샤 안질환 치료용 경피 흡수형 제제, 그 사용, 및 안질환 치료약의 눈의 국소 조직으로의 이행 방법
US7887842B2 (en) * 2003-02-07 2011-02-15 Teikoku Pharma Usa, Inc. Methods of administering a dermatological agent to a subject
CN1829490A (zh) * 2003-07-01 2006-09-06 托德·迈巴赫 包含治疗剂的薄膜
KR101388336B1 (ko) 2005-02-28 2014-04-22 데이고꾸세이약꾸가부시끼가이샤 플루르비프로펜 함유 외용 첩부제
JP2008533153A (ja) * 2005-03-14 2008-08-21 マクロケム コーポレイション ヒトの皮膚を介したマクロライドの浸透増強
PL2117521T3 (pl) * 2006-11-03 2012-11-30 Durect Corp Transdermalne systemy dostarczania zawierające bupiwakainę
JP5651020B2 (ja) * 2008-02-14 2015-01-07 エイブリィ・デニソン・コーポレイション 流体吸収性接着品
US8900626B2 (en) * 2011-06-20 2014-12-02 Senju Usa, Inc. Transdermal drug delivery system and method of using the same
US11311423B2 (en) * 2012-12-19 2022-04-26 Nichiban Co., Ltd. Facial patch

Also Published As

Publication number Publication date
RU2015129097A (ru) 2017-01-23
CN104955426A (zh) 2015-09-30
US20140171886A1 (en) 2014-06-19
US9211397B2 (en) 2015-12-15
CA2887589A1 (en) 2014-06-26
CN104955426B (zh) 2019-01-11
EP2934403A2 (en) 2015-10-28
EP2934403B1 (en) 2018-03-21
CA2887589C (en) 2021-03-09
ES2666143T3 (es) 2018-05-03
KR102182433B1 (ko) 2020-11-24
JP2016503056A (ja) 2016-02-01
MX2015007611A (es) 2015-12-15
JP6288863B2 (ja) 2018-03-07
WO2014099894A3 (en) 2014-10-23
KR20150095895A (ko) 2015-08-21
EP2934403A4 (en) 2016-06-08
WO2014099894A2 (en) 2014-06-26

Similar Documents

Publication Publication Date Title
MX371393B (es) Parche para tratamiento de enfermades del parpado que contiene clobetasol.
MX358176B (es) El uso de intensificadores, posiblemente asociados con riboflavina, asi como composiciones oftalmicas correspondientes para reticulacion de la cornea, en el tratamiento de queratocono o de otras alteraciones ectasicas de la córnea.
IN2015DN02936A (es)
MX2015009037A (es) Enjuague nasal con miel.
MX2016001023A (es) Formulaciones que contienen dapagliflozina amorfa.
HK1153636A1 (en) Ophthalmic devices for the controlled release of active agents
CO6630189A2 (es) Compuestos heterocíclicos de nitrógeno útiles como inhibidores de pde10
BR112012018386A8 (pt) "inibidores isoindolinona de fosfatidilinositol 3-quinase"
MY175318A (en) Androgen composition for treating an opthalmic condition
NZ610034A (en) Prevention of adverse effects caused by cd3 specific binding domains
TN2009000381A1 (en) C5 antigens and uses thereof
WO2012142569A3 (en) Decellularized extracellular matrix
MX2007010900A (es) Sistema terapeutico transdermico no fibroso y metodo para su produccion.
AR071598A1 (es) Uso de epotilona dpara el tratamiento de enfermedades asociadas a tau incluso enfermedad de alzheimer
WO2013036513A3 (en) Medical bandages with a skin adhesion reducing material
NZ611920A (en) Percutaneous absorption preparation containing rivastigmine
RU2016109634A (ru) Способы и композиции для лечения синдрома дефицита внимания и гиперактивности, тревожности и бессонницы с применением трансдермальных композиций на основе дексмедетомидина
MX2015008286A (es) Composiciones multipolimericas para liberación transdermica de farmaco.
GEP20196969B (en) New therapeutical composition containing apomorphine as active ingredient
MY187105A (en) "process for cold bonding rubber on metal substrates"
MX2020003044A (es) Dispositivo de administración transdérmica de dextrometorfano.
WO2013055158A3 (ko) 편광판용 접착제 및 이를 포함하는 편광판
WO2017218942A8 (en) COMPOSITIONS AND METHODS FOR TREATING DRY SYNDROME AND OTHER NON-KERATINIZED EPITHELIAL SURFACES WITH TRAUMA OCCURRENCE
WO2009152052A8 (en) Methods of treating alpha adrenergic mediated conditions
MX2015010967A (es) Formulaciones transdermicas de laquinimod.

Legal Events

Date Code Title Description
FG Grant or registration